GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » EBIT per Share

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) EBIT per Share : ₽4.56 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC EBIT per Share?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share for the three months ended in Dec. 2023 was ₽1.70. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₽4.56.

During the past 12 months, the average EBIT per Share Growth Rate of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC was 16.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 4.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was -2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share or its related term are showing as below:

MIC:GEMA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -5.8   Med: -4.6   Max: 4.1
Current: 4.1

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC was 4.10% per year. The lowest was -5.80% per year. And the median was -4.60% per year.

MIC:GEMA's 3-Year EBIT Growth Rate is ranked worse than
57.99% of 507 companies
in the Healthcare Providers & Services industry
Industry Median: 8.6 vs MIC:GEMA: 4.10

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT for the three months ended in Dec. 2023 was ₽25.4 Mil.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC EBIT per Share Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC EBIT per Share Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial 9.22 8.68 9.54 7.76 10.67

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 2.44 2.86 - 1.70

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=159.34/14.930
=10.67

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

EBIT per Share(Q: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=25.359/14.930
=1.70

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₽4.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC EBIT per Share Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Traded in Other Exchanges
N/A
Address
St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines